NovoCure Limited Ordinary Shares (NVCR)
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
NovoCure Limited Ordinary Shares (NVCR) is listed on Nasdaq, where it has traded since October 2, 2015.
- Listed On
- Nasdaq
- Listed Since
- October 2, 2015
- Employees
- 1,605
- Market Cap
- $1.6B
About NovoCure Limited Ordinary Shares
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 206 institutions reported holding NVCR, with 103.2 million shares worth $1.6 billion in aggregate. The largest reported holder was FMR, with 17.4 million shares worth $263.2 million. Of the 5 largest holders listed below, 3 added shares and 2 reduced their positions during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| FMR | 17,373,078 | $263M | Added 1.78% |
| BlackRock | 13,413,699 | $203M | Added 1.67% |
| Vanguard | 12,094,788 | $183M | Added 2.37% |
| Soleus Capital Management | 9,913,401 | $150M | Reduced 5.52% |
| Morgan Stanley | 4,522,389 | $69M | Reduced 0.42% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is NVCR?
NovoCure Limited Ordinary Shares (NVCR) is listed on Nasdaq, where it has traded since October 2, 2015.
Who are the largest institutional holders of NVCR?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of NVCR were FMR, BlackRock and Vanguard.
How many institutions own NVCR?
206 institutions reported a position in NVCR for the quarter ended June 30, 2026, worth $1.6 billion in total.
Did institutions buy or sell NVCR last quarter?
Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for NVCR.
Every reported institutional holder, plus insider and congressional trades in NVCR, on SentiSense.